Multipotent mesenchymal stromal cells (MSCs) are primitive cells capable of restoring damaged mesenchyme and with the ability to differentiate into mature cells of bone, cartilage, muscle, fat, nerve or fibrous tissues. MSCs are therefore good candidates for applications in regenerative medicine and cell based therapy. They regenerate through self-renewal, differentiational capacity, immune modulation and secretion of bioactive molecules. Authors present a review of MSCs applications in otorhinolaryngology. The major interest is focused on phonosurgery, sensorineural deafness and reconstruction of large tissue defects with bone, cartilage or soft tissue replacement. Current evidence of MSCs treatment efficacy in otorhinolaryngology is based on animal models. The true impact on clinical treatment will not be known until clinical studies prove functional outcomes in human medicine.

Department of Oncology and Radiotherapy Charles University Prague Faculty of Medicine in Hradec Kralove Czech Republic

Department of Otorhinolaryngology and Head and Neck Surgery University Hospital Hradec Kralove Charles University Prague Faculty of Medicine in Hradec Kralove Czech Republic

Laboratory of Tissue Culture and Stem Cells Institute of Experimental Medicine Academy of Science of the Czech Republic Czech Republic

References provided by Crossref.org

An Effect of Cyclosporin A in a Treatment of Temporal Bone Defect Using hBM-MSCs

The Transplantation of hBM-MSCs Increases Bone Neo-Formation and Preserves Hearing Function in the Treatment of Temporal Bone Defects - on the Experience of Two Month Follow Up